Abstract
Torsades de pointe were described by Dessertenne as a variety of non-sustained polymorphous ventricular tachycardia in subjects presenting bradycardia due to atrio-ventricular block [1]. The name ‘torsades de pointe’ is now universally accepted and is preferred to other synonyms referring to the same aspect of the waves in the ectopic ventricular complexes: ventricular pseudofibrillation [2], transitory ventriculation [3], transitory recurrent ventricular fibrillation [4], paroxistic ventricular fibrillation [5], cardiac ballet [6], ventricular fibrilloflutter [7], polymorphious ventricular tachycardia [8], multiform ventricular tachycardia [9] and helicoidal tachycardia [10].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abinader EG, Shahar J, P. Puech: Possible female preponderance in prenylamine - induced Torsades de pointes’ Tachycardia. Cardiology, 1983; 70: 37–40.
Azpitarte Almagro J, Casero A, Melgares R: Torsade de pointes inducida por disopiramida. Presentación de un caso de evolución fatal. Rev Esp Cardiolog 1984; 37: 145–148.
Bardy GH, Ungerleider RM, Smith WM, Ideker RE: A mechanism of Torsades de pointes in a canine model. Circulation 1983; 67: 52–59.
Bauman JL, Bauernfeind RA, Hoff JV, Strasberg B, Swiryn S, Rosen KM: Torsades de pointes due to quinidine: observations in 31 patients. Am Heart J 1984; 107: 425–430.
Bennett KR: Torsade de pointes and mitral valve prolapse. Am J Cardiol 1980; 45: 715.
Bens JL, Duboisset, Quiret JC, Lesbre J Ph, Bernasconi P: Syncopes par torsades de pointe induites ou favorisées par la prénylamine. Arch Mal Cœur 1973; 66: 1247–1254.
Botti G, Bonatti V: Pathogenesis of ventricular arrhythmias in long QT syndromes. In: Masoni A, Alboni P (ed) Cardiac electrophysiology today. Academic Press, London and New-York, 1982; 291–305.
Brachmann J, Scherlag BJ, Rosenstraukh LV, Lazzara R: Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia. Circulation 1983; 68: 846–856.
Brochier M, Fauchier JP: Torsades de pointes et ré-entrées provoquées par les antiarhyth- miques. Arch Mal Cœur 1978; 71: 477–482.
Castellanos A, Salhanick L: Electrocardiographic pattern of procainamide toxicity. Am J Med Sci 1967; 253: 52–60.
Coumel Ph, Fidelle J, Lucet V, Attuel P, Bouvrain Y: Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children. Report of four cases. Br Heart J 1978; 40 (suppl): 28–37.
Damiano BP, Rosen MR: Effects of pacing on triggered activity induced by early after depolarizations. Circulation 1984; 69: 1013–1025.
Dany F, Merle L, Goudoud JC, Liozon F, Blanc P, Bouvot JC, Nicot G, Dangoumau J: Les accidents cardiaques de la vincamine. Therapie 1981; 36: 55–64.
Dessertenne F: La tachycardie ventriculaire à deux foyers opposés variables. Arch Mal Cœur 1966; 59: 263–272.
Evans TR, Curry PVL, Fitchet DH, Krikler DM: ‘Torsades de pointes’ initiated by electrical stimulation. J Electrocardiol 1976; 9: 255–258.
Fauchier JP, Lanfranchi S, Ginies G, Raynaud R: Syncopes par ‘torsades de pointe’ au cours d’un traitement par la chloroquine. Ann Cardiol Angeiol 1974; 23: 341.
Fazekas T, Kiss Z: Torsade de pointes ventricular tachycardia associated with lidoflazine therapy. Eur Heart J 1984; 5: 343.
Fontaine G, Frank R, Lascault G, Tonet JL, Fillette F, Grosgogeat Y: Torsades de pointes favorisées par stimulations ventriculaires à rythme lent. Arch Mal Cœur 1983; 76: 918–924.
Forfar JC, Gribbin B: Torsade de pointes after amiodarone with drawal of wild hypokalaemia on repolarization. Eur Heart J 1984; 5: 510–512.
Fowler NO, Mc Call D, Chou T, Holmes JC, Hanenson IB: Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol 1976; 37: 223–230.
Goldsmith S, From AHL: Arsenic-induced atypical ventricular tachycardia. N Engl J Med 1980; 303: 1096–1098.
Gonzalez-Hermosillo JA, Cardenas M, Hurtado BL, Vidal J: Taquicardia ventricular helicoidal (‘torsades de pointes’). Arch Inst Cardiol México 1977; 47: 5.
Grenadier E, Alpan G, Maor N, Keidar S, Binenboim C, Margulies T, Palant A: Polymorphous ventricular tachycardia in acute myocardial infarction. Am J Cardiol 1984; 53: 1280–1283.
Guillou M, Ceriou A, Blanc JJ, Boschat J, Granatelli D, Penther D: Torsades de pointes; responsabilité eventuelle d’un vasodilatateur périphérique, le fénoxédil. Nouv Presse Méd 1975; 4: 29.
Hanley SP, Hampton JR: Ventricular arrhythmia associated with lidoflazine: side-effects observed in a randomized trial. Eur Heart J 1983; 4: 889–893.
Herrmann HC, Kaplan LM, Bierer BE: QT prolongation and Torsades de pointes tachycardia produced by the tetracylic anti-depressant agent maprotiline. Am J Cardiol 1983; 51: 904–906.
Horowitz LN, Greespan AM, Spielman SR, Josephson ME: Torsades de pointes: electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Circulation 1981; 63: 1120–1128.
Isner JM, Sours HE, Paris AL, Ferrans VJ, Roberts WC: Sudden unexpected death in avid dieters using the liquid protein modified fast diet: observations in 17 patients ant the role of the prolonged QT interval. Circulation 1979; 60: 1401–1412.
Jenzer HR, Hagemeijer F: Quinidine syncope: Torsades de pointes with low quinidine plasma concentrations. Eur J Cardiol 1976; 4: 447–451.
Keren A, Tzivoni D, Gavish D, Levi J, Gottlieb S, Benhorin J, Stern S: Etiology, warning signs and therapy of Torsade de pointes. A study of ten patients. Circulation 1981; 64: 1167–1174.
Khan M, Logan KR, Mc Coomb JM, Adger AAJ: Management of recurrent ventricular tachy-arrhythmias associated with QT prolongation. Am J Cardiol 1981; 47: 1301–1308.
Kirkler DM, Curry PVL: ‘Torsades de pointes’ and atypical ventricular tachycardia. Brit Heart J 1976; 38: 117–120.
Kiss Z, Fazckas T: Arrhythmias in organophosphate poisonings. Acta Cardiol 1979; 34: 3223–2330.
Langou RA, van Dyke C, Tahan SR, Cohen RS: Cardiovascular manifestacions of tricyclic anti-depressant overdose. Am Heart J 1980; 100: 458–464.
Laprevotte-Heully MC, Lambert H, Larcan A: Syncopes par torsades de pointes. Rôle de la vincamine. A propos de 3 observations. Nouv Presse Méd 1974; 3: 13.
Lathour H, Puech P, Hertault J, Stefanou G, Grolleau R, Simorre R, Sat M: Syncopes après reduction de fibrillation auriculaire par choc électrique et hydroquinidine. Arch Mal Cœur 1966; 59: 533.
Leclercq JF, Maisonblanche P, Cauchemez B, Atuel P, Coumel Ph: Troubles du rythme ventriculaires polymorphes familiaux incessants avec anomalies de la repolarisation ventriculaire forme frontière du syndrome du QT long congenital? Arch Mal Cœur 1984; 77: 1013–1019.
Leclerq JF, Kural S, Valere PE: Bépridil et torsades de pointe. Arch Mal Cœur 1983; 76: 341–347.
Lestringant A: Torsades de pointe sous traitement par bêtalactamines. Thèse Montpellier, mai 1982.
Loeb HS, Pietras RS, Gunnar RM, Tobin JR: Paroxysmal ventricular fibrillation in two patients with hypomagnesemia. Treatment by transvenous pacing. Circulation 1968; 37: 210.
Lucet V, Dongoc D, Toumieux MC, Mercier JN, Fidelle J: Torsades de pointe chez l’enfant. Rôle possible du diphémanil. Presse Méd 1984; 13: 1979.
Ludomirsky A, Klein HO, Sarelli P, Becker B, Hoffman S, Taitelman U, Barzilai J, Lang R, David D, Disegni E, Kaplinsky E: QT prolongation and polymorphous (‘Torsade de pointes’) ventricular arrhythmias associated with organophosphorous insecticide poisoining. Am J Cardiol 1982; 49: 1654–1658.
Luomanmäki K, Keikkilä J, Hartikainem M: T wave alternons associated with heart failure and hypomagnesemia in alcoholic cardiomyopathy. Eur J Cardiol 1975; 3: 1167.
McCoomb JM, Logan KR, Khan MM, Geddes JS, Adgey AAJ: Amiodarone induced ventricular fibrillation. Eur J Cardiol 1980; 11: 381–385.
McKibbin JK, Pololck WA, Barlow JB, Scott Millar RN, Obel IW: Sotalol, hypokalaemia, syncope and torsade de pointes. Br Heart J 1984; 51: 157–162.
McWilliam JA: Some applications of physiology to medicine. II, Ventricular fibrillation and sudden death. Br Med J 1923; 2: 215.
Mikolich JR, Jacobs WC, Fletcher GF, Cardiac arrhythmias in patients with acute cerebro vascular accidents. JAMA 1981; 246: 1314–1317.
Motte G, Laine JF, Sebag C, Davy JM: Torsades de pointe favorisées par l’atropine. Nouv Presse Méd 1982; 11: 3571–3572.
Motte G, Coumel Ph, Abitbol G, Dessertenne F, Slama R: Le synchrone QT long et syncopes par Torsades de pointes. Arch Mal Cœur 1970; 63: 831–853.
Navarro-López F, Cinca J, Sanz G, Periz A, Magrina J, Betriu A: Isolated T wave alternans. Am Heart J 1978; 95: 369–374.
Neuvonen PH, Elonen E, Vuorenmaa T, Laasko M: Prolonged QT interval and severe tachyarrhythmias, common features of sotalol intoxication. Eur J Clin Pharmacol 1981; 20: 85–89.
Normand JP, Kahn JC, Mialet G, Bardet J, Bourdarias JP, Mathivat A: Torsades de pointes induites ou favorisées par la prénylamine. Ann Cardiol Angeiol 1974; 23: 527–533.
Olshansky B, Martins J, Hunt S: N-acetylprocainamide causing torsades de pointes. Am J Cardiol 1982; 50: 1439–1441.
Pernot C, Henry M, Aigle JC: Syndrome cardio-auditif de Jerwell et Torsades de pointes. Arch Mal Cœur 1972; 65: 261.
Puech P, Bosc E, Grolleau R, Cabasson J, Mellet JM, Ferriere M: Troubles du rythme cardiaque lies aux fénoxédil. Ann Cardiol Angeiol 1976; 25: 297–302.
Puritz R, Henderson MA, Baxer SN, Chamberlain DA: Ventricular arrhythmias caused by prenylamine. Br Med J 1977; 2: 608–609.
Ranquin R, Parizel G: Ventriculor fibrillo-flutter (torsade de pointe): an established electrocardiographic and clinical entity. Angiology 1977; 28: 115–118.
Salvador M, Thomas C, Mazeno M, Conte J, Meriel P, Lesbre P: Troubles du rythme directement induits ou favorisées par les déplétions potassiques. Arch Mal Cœur 1970; 63: 230–257.
Santinelli V, Chiariello M, Santinelli C, Condorelli M: Ventricular tachyarrhythmias complicating amiodarone therapy in the presence of hypokaliemia. Am J Cardiol 1984; 53: 1462–1463.
Sawaya JJ, Rubeiz GA: Prinzmetal’s angina with Torsades de pointe ventricular tachycardia. Acta Cardiol 1980; 35: 47.
Scagliotti D, Strasberg B, Hai HA, Kehoe R, Rosen K: Aprindine-induced polymorphous ventricular tachycardia. Am J Cardiol 1982; 49: 1297, 1300.
Schwartz SP, Hallinger LN: Transient ventricular fibrillation. Amer Heart J 1954; 48: 390–404.
Sclarovsky S, Lewin RF, Krakoff O, Strasberg B, Arditti A, Agmon J: Amiodarone induced polymorphous ventricular tachycardia. Am Heart J 1983; 105: 6–11.
Sclarovsky S, Strasberg B, Lewin RF, Agmon J: Polymorphous ventricular tachycardia: clinical features and treatment. Am J Cardiol 1979; 44: 339.
Selzer A, Wray HW: Quinidine syncope, paroxysmal ventricular fibrillation occuring during treatment of chronic atrial arrhythmias. Circulation 1964; 30: 17.
Slama R, Coumel Ph, Motte G, Gourdon R, Wayenberger M, Touche S: Tachycardies ventriculaires. Fontières morphologiques entre les dysrythmies ventriculaires. Arch Mal Cœur 1973; 66: 1401–1411.
Smirk FM: Cardiac ballet: repetitions of complex electrocardiographic patterns. Br Heart J 1969; 31: 426.
Soffer J, Dreifus LS, Michelson EL: Polymorphous ventricular tachycardia associated with normal and long QT intervals. Am J Cardiol 1982; 49: 2021–2029.
Strasberg B, Sclarovsky S, Erdberg A, Duffy CE, Lam W, Swiryn S, Agmon J, Rosen KM: Procainamide-induced polymorphous ventricular tachycardia. Am J Cardiol 1981; 47: 1309–1314.
Strasberg B, Welch W, Palileo E, Swiryn S, Bauernfeind R, Rosen KM: Familial inducible Torsade de pointes with normal QT interval. Eur Heart J 1983; 4: 383–391.
Tamura K, Tamura T, Yoshida S, Inui M, Fukuhara N: Transient recurrent ventricular fibrillation due to hypopotassemia with special note on the U wave. Jpn Heart J 1967; 8: 652.
Taylor GJ, Crampton RS, Gibson RS, Stebbins PT, Waldman MT, Beller GA: Prolonged QT interval at onset of acute myocardial infarction in predicting early phase ventricular tachycardia. Am Heart J 1981; 102: 16–24.
Tzivoni D, Keren A, Cohen AM, Loebel H, Zahavi I, Chenzbraun A, Stern S: Magnesium therapy for Torsades de pointes. Am J Cardiol 1984; 53: 528–530.
Veglia L, Scandifio T, Guenicchio G: ‘Torsioni di punta’ e amiodarone. G Ital Cardiol 1978; 8:1025.
Vidal J, Hernández Guevara JL, Cárdenas M: Taquicardia ventricular helicoidal, ‘Torsades de pointe’ en el infarto agudo del miocardio. Arch Inst Cardiol México, 1983; 53: 237–245.
Wald RW, Waxman MB, Colman JM: Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine. J Electrocardiol 1981; 14: 301–307.
Wellens HJ: Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias. Circulation 1978; 57: 845–853.
Wellens HJ: Quoted by Fontaine et al. [18].
Wiggers CJ: Studies on ventricular fibrillation caused by electric shock. Am Heart J 1929; 5: 351.
Zilcher H, Glogar D, Kaindl F: Torsades de pointe: occurence in myocardial ischaemia as a separate entity. Multiform ventricular tachycardia or not? Eur Heart J 1980; 1: 63–71.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Puech, P., Gallay, P. (1988). Torsades de Pointe. In: de Luna, A.B., Betriu, A., Permanyer, G. (eds) Therapeutics in Cardiology. Developments in Cardiovascular Medicine, vol 81. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1333-2_8
Download citation
DOI: https://doi.org/10.1007/978-94-009-1333-2_8
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7094-2
Online ISBN: 978-94-009-1333-2
eBook Packages: Springer Book Archive